title: Central nervous system toxicity related to FK506 in patients with Behçet's disease.
authors.forename: T
authors.initials: T
authors.lastname: Igarashi
authors.forename: Y
authors.initials: Y
authors.lastname: Ishigatsubo
authors.forename: S
authors.initials: S
authors.lastname: Ohno
authors.forename: A
authors.initials: A
authors.lastname: Ueda
authors.forename: T
authors.initials: T
authors.lastname: Okubo
authors.forename: S
authors.initials: S
authors.lastname: Tanaka
authors.forename: Y
authors.initials: Y
authors.lastname: Katsumata
authors.forename: T
authors.initials: T
authors.lastname: Sakane
authors.forename: S
authors.initials: S
authors.lastname: Ohno
mesh_terms: D000328:Adult; D001528:Behcet Syndrome / Q000188:drug therapy*; D001927:Brain Diseases / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D011149:Pons / Q000473:pathology; D016559:Tacrolimus / Q000009:adverse effects*
chemical_list: D016559:Tacrolimus